Chromosomal losses and gains in meningiomas: Comparative genomic hybridization (CGH) study of the whole genome

Abstract

We investigated chromosomal aberrations in meningiomas using newly developed comparative genomic hybridization (CGH) technique and compared the results with the proliferating potential of the tumors. This technique permits the entire genome to be surveyed in one session of experiments. Our results revealed chromosomal aberrations in 5 out of 10 (50%) of the tumor samples studied. Losses of the distal parts of chromosome 1p (5 out of 10) and 22q (3 out of 10) were the two most frequent chromosomal aberrations. Losses and/or gains in other regions were only sporadic. The MIB-1 staining indices (MIB-511 %) were 1.9 ± 0.9% (mean ± SD) in benign (n = 8)1 4.5% in atypical (n = 1)1 and 11.7% in anaplastic (n = 1) meningiomas. The comparison of MIB-51 between the tumors with (2.3 ± 0.6%) and without (7.6 ± 0.3%) chromosomal aberrations demonstrated a trend towards an increased MIB-51 in meningiomas with chromosomal aberrations (p < 0.07) by unpaired 5tudent1s t-test. This study suggests that alterations in chromosomes 1p and 22q could be a primary focus of further detailed assessment of tumorigenesis and in understanding the biological behavior of meningiomas. [Neural Res 1998; 20: 612-616]